Clinical Trial Update: Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating spheroidal mesenchymal stem cells for Retinitis Pigmentosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Spheroidal mesenchymal stem cells

Snippet

Sponsor: Acibadem University | Conditions: Retinitis Pigmentosa, Stem Cell Transplant | Phase 1, Phase 2 | Status: COMPLETED